Global Gynecological Devices Market 2023-2030

Description

List of Tables

Global Gynecological Devices Market Size, Share & Trends Analysis Report by Endoscopy Devices (Hysteroscope, Resectoscope, Colposcope, Laparoscope, and Endoscopic Imaging Systems), by Endometrial Ablation Devices (Balloon Ablation Devices, Hydrothermal Ablation Devices, Radiofrequency Ablation Devices, and Others) and by Contraceptive Devices (Temporary Birth Control, Permanent Birth Control, Diagnostic Imaging Systems, Fluid Management Systems, and Others), Forecast Period (2023-2030)

The global gynecological devices market is anticipated to grow at a CAGR of 7.9% during the forecast period (2023-2030). The market's growth is attributed to the growing demand for improved diagnostics across the globe. Devices that have improved diagnostic capabilities are in high demand, as it contains an increased focus on early detection and preventive healthcare. For Instance, in October 2023, Olympus Corporation, launched next-generation EVIS X1 endoscopy system. The TXI technology improves visibility of lesions and polyps, RDI detects deep blood vessels and bleeding pigmentation, BAI-MAC improves brightness levels in dark areas, and NBI observes mucosal and vascular patterns on the EVIS X1 endoscopy equipment. It additionally features a touch panel for faster processes and a MyCV mode for personalized image configurations.

Segmental Outlook

The global gynecological devices market is segmented on the endoscopy devices, endometrial ablation devices, and contraceptive devices. Based on the endoscopy devices, the market is sub-segmented into hysteroscope, resectoscope, colposcope, laparoscope, and endoscopic imaging systems. Based on the endometrial ablation devices, the market is sub-segmented into balloon ablation devices, hydrothermal ablation devices, radiofrequency ablation devices, and others. Furthermore, on the basis of contraceptive devices, the market is sub-segmented into temporary birth control, permanent birth control, diagnostic imaging systems, fluid management systems, and others. The laparoscope enterprise subcategory is expected to capture a significant portion of the market share within the endoscopy devices segment. The growth can be attributed to the numerous benefits of laparoscopic surgeries, including less blood loss, shorter hospital stays, and fewer intraoperative and postoperative issues.

The Hysteroscope Sub-Segment is Anticipated to Hold a Considerable Share of the global Gynecological Devices Market

Among the endoscopy devices, the hysteroscope sub-segment is expected to hold a considerable share of the global gynecological devices market. The segmental growth is attributed to the growing demand for improvement of skills and care quality. The improved training methods result in more skilled practitioners, ultimately improving the quality of treatment produced to hysteroscopic patients. For instance, in February 2021, VirtaMed launched hysteroscopy and gynecological laparoscopy mixed reality platform. Hysteroscopy training covers 16 instances for MyoSure tissue removal in addition to over 50 cases in diagnostics, polypectomy, myomectomy, tissue ablation, and advanced electrosurgical resection, all with competency-based objective feedback and complication management. The Gynecological Laparoscopy Simulator simulates surgical situations.

Regional Outlook

The global gynecological devices market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Asia-Pacific is anticipated to hold a prominent share of the market across the globe, owing to the growing awareness of birth control and contraception can boost regional product demand as a result of government seeks to reduce population growth. According to the World Health Organization, in September 2023, the demand for family planning among women has increased significantly over the last two decades, rising from 900 million in 2000 to approximately 1.1 billion in 2021. In addition, the adoption of contemporary contraceptive techniques has increased, rising from 663 million in 2000 to 851 million in 2020. According to projections, an additional 70 million women are projected to exceed the results by 2030, establishing a favorable trend in contraceptive prevalence rates, that have increased from 47.7% to 49.0% between 2000 and 2020.

Facts

According to the World Health Organization (WHO), in 2022, global contraceptive prevalence of any method was estimated at 65% and of modern methods at 58.7% for married or in a union women (3).

The North America Region is Expected to Grow at a Significant CAGR in the global Gynecological Devices Market

Among all regions, the North America regions is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to the optical technologies in a variety of applications across the region. The deployment of proceeds across endoscopy, pulse oximetry, laparoscopy, ophthalmology, and robotic surgery within the optical sector indicates the numerous applications of optical technologies. Its subsector targets distinctive clinical demands, ranging from minimally invasive surgical procedures to accurate diagnostic instruments, to satisfy a wide range of healthcare needs. According to the National Institute of Health (gov.) in December 2023, in imagining technology development, it is essential to evaluate the expenditure in research and development. By analyzing funding from the US National Institutes of Health (NIH), it emerged that radiological sectors receive $8.5 billion per year, accounting for 70% of device-based research, while optical sectors receive $3.6 billion per year, accounting for 30% of research, divided into microscopy, endoscopy, pulse oximetry, laparoscopy, ophthalmology, and robotic surgery. However, several technologies, such as MRI, nuclear medicine, and microscopy, have significant financing rates, with over 30% investment per technology valuation.

Market Players Outlook

The major companies serving the gynecological devices market includes Elekta GmbH, FUJIFILM Corp., GE HealthCare Technologies Inc., Hologic, Inc., Johnson & Johnson Services, Inc. and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in in February 2023, Samsung Launched new AI-Enabled OB/GYN Ultrasound System. The use of the Advanced MV-FlowTM feature and a large organic light-emitting diode (OLED) display that allows improved characterization of varied ultrasound pictures, delivers 2D and 3D imaging of microcirculatory and sluggish blood.

The Report Covers:

Market value data analysis of 2022 and forecast to 2030.
Annualized market revenues ($ million) for each market segment.
Country-wise analysis of major geographical regions.
Key companies operating in the global gynecological devices market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
Analysis of market-entry and market expansion strategies. Competitive strategies by identifying 'who-stands-where' in the market.

Product Code: OMR2027989

1. Report Summary

Current Industry Analysis and Growth Potential Outlook
1.1. Research Methods and Tools
1.2. Market Breakdown
- 1.2.1. By Segments
- 1.2.2. By Region

2. Market Overview and Insights

2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
- 2.2.1. Key Findings
- 2.2.2. Recommendations
- 2.2.3. Conclusion

3. Competitive Landscape

3.1. Key Company Analysis
3.2. Abbott Laboratories
- 3.2.1. Overview
- 3.2.2. Financial Analysis
- 3.2.3. SWOT Analysis
- 3.2.4. Recent Developments
3.3. Becton, Dickinson, and Co.
- 3.3.1. Overview
- 3.3.2. Financial Analysis
- 3.3.3. SWOT Analysis
- 3.3.4. Recent Developments
3.4. Boston Scientific Corp.
- 3.4.1. Overview
- 3.4.2. Financial Analysis
- 3.4.3. SWOT Analysis
- 3.4.4. Recent Developments
3.5. Key Strategy Analysis

4. Market Segmentation

4.1. Global Gynecological Devices Market by Endoscopy Devices
- 4.1.1. Hysteroscope
- 4.1.2. Resectoscope
- 4.1.3. Colposcope
- 4.1.4. Laparoscope
- 4.1.5. Endoscopic Imaging Systems
4.2. Global Gynecological Devices Market by Endometrial Ablation Devices
- 4.2.1. Balloon Ablation Devices
- 4.2.2. Hydrothermal Ablation Devices
- 4.2.3. Radiofrequency Ablation Devices
- 4.2.4. Others ( Cryoablation Devices,and Microwave Ablation Devices)
4.3. Global Gynecological Devices Market by Contraceptive Devices
- 4.3.1. Temporary Birth Control
- 4.3.2. Permanent Birth Control
- 4.3.3. Diagnostic Imaging Systems
- 4.3.4. Fluid Management Systems
- 4.3.5. Others (Pelvic Floor Repair Devices, and Fertility Tracking Devices)

5. Regional Analysis

5.1. North America
- 5.1.1. United States
- 5.1.2. Canada
5.2. Europe
- 5.2.1. UK
- 5.2.2. Germany
- 5.2.3. Italy
- 5.2.4. Spain
- 5.2.5. France
- 5.2.6. Rest of Europe
5.3. Asia-Pacific
- 5.3.1. China
- 5.3.2. India
- 5.3.3. Japan
- 5.3.4. South Korea
- 5.3.5. Rest of Asia-Pacific
5.4. Rest of the World

6. Company Profiles

6.1. Cook Group Inc.
6.2. Elekta GmbH
6.3. FUJIFILM Corp.
6.4. GE HealthCare Technologies Inc.
6.5. Hologic, Inc.
6.6. Johnson & Johnson Services, Inc.
6.7. KARL STORZ SE & Co. KG
6.8. Medtronic Pvt.Ltd.
6.9. Olympus Group
6.10. Richard Wolf GmbH
6.11. Shimadzu Corp.
6.12. Smith & Nephew plc
6.13. Stryker Corp.
6.14. Teleflex Medical Pvt. Ltd.
6.15. The Cooper Companies, Inc.